Extrahepatic cholangiocarcinoma: A comparison of patients with resected proximal and distal lesions Journal Article


Authors: Allen, P. J.; Reiner, A. S.; Gonen, M.; Klimstra, D. K.; Blumgart, L. H.; Brennan, M. F.; D'Angelica, M.; DeMatteo, R.; Fong, Y.; Jarnagin, W. R.
Article Title: Extrahepatic cholangiocarcinoma: A comparison of patients with resected proximal and distal lesions
Abstract: Purpose. Disease-specific survival (DSS) for proximal bile duct cancer has been reported to be worse than for carcinoma of the distal duct. Methods. Review of two prospectively maintained databases identified 204 patients who underwent resection for extrahepatic cholangiocarcinoma (proximal: n = 106, 52%; distal: n = 98, 48%) between December 1987 and December 2005. Patient, tumor, and treatment-related variables were reviewed. Analyses were performed to compare tumor presentation, treatment, and DSS between patients with resected proximal and distal lesions. Results. Median follow-up for the 204 resected patients was 24 months (range 1-165 months) and 56 months for those alive at last follow-up. Combined liver/bile duct resection was performed in 82% of patients with proximal lesions, and pancreaticoduodenectomy was performed in 92% of patients with distal lesions. Patients experienced similar postoperative length of stay (median: proximal, 13 days vs. distal, 13 days; p = 0.64) and operative mortality (30-day: proximal, 4% vs. distal, 3%; p = 1.0, Fishers). Margin positive rates were similar (proximal, 23% vs. distal, 15%; p = 0.20). Estimated five-year DSS for all patients was 35%. Tumor location (proximal vs. distal) was not associated with five-year estimated DSS (proximal, 29% vs. distal, 43%; p = 0.44). Factors associated with five-year DSS included stage at presentation (node negative, 42% vs. node positive, 22%; p = <0.001), differentiation (papillary, 53% vs. non-papillary, 27%; p = 0.01), and margin status (margin negative 42% vs. margin positive 27%; p < 0.001). Conclusions. These results suggest that patients with resected proximal and distal cholangiocarcinoma will experience similar operative outcomes and DSS.
Keywords: survival; adult; controlled study; aged; major clinical study; cancer localization; conference paper; outcome assessment; follow up; lymph node metastasis; prospective study; pancreaticoduodenectomy; data base; medical record review; length of stay; liver resection; surgical mortality; bile duct carcinoma; biliary tract surgery; cholangiocarcinoma; bile ducts
Journal Title: HPB
Volume: 10
Issue: 5
ISSN: 1365-182X
Publisher: Elsevier Science, Inc.  
Date Published: 2008-10-01
Start Page: 341
End Page: 346
Language: English
DOI: 10.1080/13651820802276630
PROVIDER: scopus
PMCID: PMC2575674
PUBMED: 18982150
DOI/URL:
Notes: --- - "Cited By (since 1996): 4" - "Export Date: 17 November 2011" - "CODEN: HPBIF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anne S Reiner
    248 Reiner
  2. Murray F Brennan
    1059 Brennan
  3. Leslie H Blumgart
    352 Blumgart
  4. Ronald P DeMatteo
    637 DeMatteo
  5. Mithat Gonen
    1028 Gonen
  6. David S Klimstra
    978 Klimstra
  7. Peter Allen
    501 Allen
  8. William R Jarnagin
    903 Jarnagin
  9. Yuman Fong
    775 Fong